Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.45B | 24.38B | 23.86B | 23.95B | 23.22B | 22.50B |
Gross Profit | 8.43B | 8.68B | 7.29B | 9.27B | 10.02B | 9.53B |
EBITDA | 2.49B | 2.87B | 1.66B | 2.72B | 4.18B | 4.59B |
Net Income | 1.30B | 1.51B | 603.18M | 1.44B | 2.05B | 2.46B |
Balance Sheet | ||||||
Total Assets | 21.05B | 21.18B | 22.70B | 21.30B | 20.83B | 20.47B |
Cash, Cash Equivalents and Short-Term Investments | 12.47B | 12.83B | 13.84B | 13.20B | 12.94B | 11.93B |
Total Debt | 7.00M | 6.66M | 9.91M | 13.99M | 8.68M | 57.97M |
Total Liabilities | 7.23B | 6.94B | 8.48B | 6.56B | 6.09B | 6.43B |
Stockholders Equity | 13.82B | 14.24B | 14.22B | 14.74B | 14.75B | 14.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 987.74M | 1.96B | 1.62B | 2.35B | 3.76B |
Operating Cash Flow | 0.00 | 1.21B | 2.28B | 2.20B | 3.24B | 4.09B |
Investing Cash Flow | 0.00 | -267.84M | -759.16M | -565.77M | -865.46M | -306.41M |
Financing Cash Flow | 0.00 | -1.46B | -1.46B | -1.46B | -1.50B | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥28.23B | 12.45 | 2.79% | 1.65% | -2.94% | ||
77 Outperform | ¥33.64B | 23.44 | 0.67% | 17.26% | 20.28% | ||
76 Outperform | ¥31.67B | 20.10 | 4.61% | 3.32% | 225.36% | ||
74 Outperform | ¥25.78B | 13.20 | 4.30% | 13.54% | 15.43% | ||
73 Outperform | ¥26.27B | 24.07 | 0.56% | 11.47% | 17.94% | ||
68 Neutral | ¥34.89B | 80.31 | ― | 25.51% | 95.13% | ||
57 Neutral | HK$14.47B | 9.47 | -0.60% | 4.33% | 7.09% | -37.88% |